S1082 |
Vismodegib (GDC-0449)
|
Vismodegib (GDC-0449) is a potent, novel and specific hedgehog inhibitor with IC50 of 3 nM and also inhibits P-gp with IC50 of 3.0 μM in a cell-free assay. |
-
Nat Commun, 2024, 15(1):8134
-
EBioMedicine, 2024, 101:105026
-
EMBO Rep, 2024, 25(5):2188-2201
|
|
S1146 |
Cyclopamine
|
Cyclopamine (11-deoxojervine) is a specific Hedgehog (Hh) signaling pathway antagonist of Smoothened (Smo) with IC50 of 46 nM in TM3Hh12 cells. |
-
Nat Commun, 2024, 15(1):987
-
Cell Oncol (Dordr), 2024, 10.1007/s13402-024-00939-5
-
Front Cell Dev Biol, 2024, 12:1356589
|
|
S8075 |
GANT61
|
GANT61 (NSC 136476) is an inhibitor for GLI1 as well as GLI2-induced transcription, inhibits hedgehog with IC50 of 5 μM in GLI1 expressing HEK293T cell, displays selectivity over other pathways, such as TNF and glucocorticoid receptor gene transactivation. GANT61 induces apoptosis and activates protective autophagy in LX-2 cells. |
-
EBioMedicine, 2024, 101:105026
-
Acta Pharm Sin B, 2023, 13(6):2601-2612
-
Acta Pharm Sin B, 2023, 13(6):2601-2612
|
|
S7779 |
SAG (Smoothened Agonist) HCl
|
SAG (Smoothened Agonist) HCl is a cell-permeable Smoothened (Smo) agonist with EC50 of 3 nM in Shh-LIGHT2 cells. |
-
Nat Commun, 2024, 15(1):4124
-
Nat Commun, 2024, 15(1):4124
-
bioRxiv, 2024, 2024.05.14.594243
|
|
S2151 |
Sonidegib
|
Sonidegib is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human) in cell-free assays, respectively. Phase 3. |
-
EBioMedicine, 2024, 101:105026
-
Cell Death Dis, 2024, 15(1):56
-
Cell Rep, 2024, 43(8):114532
|
|
S3042 |
Purmorphamine
|
Purmorphamine (Shh Signaling Antagonist VI), which directly binds and activates Smoothened, blocks BODIPY-cyclopamine binding to Smo with IC50 of ~ 1.5 μM in HEK293T cell and also is an inducer of osteoblast differentiation with EC50 of 1 μM. Purmorphamine can reduce both basal and induced autophagy. |
-
Nat Commun, 2024, 15(1):987
-
J Adv Res, 2024, S2090-1232(24)00106-1
-
Neural Regen Res, 2024, 19(1):205-211
|
|
S2476 |
Itraconazole
|
Itraconazole is a relatively potent inhibitor of CYP3A4 with IC50 of 6.1 nM, used as a triazole antifungal agent. Itraconazole is a potent antagonist of the Hedgehog (Hh) signaling pathway. Itraconazole suppresses the growth of glioblastoma through induction of autophagy. |
-
Front Cell Infect Microbiol, 2023, 13:1128000
-
Front Cell Infect Microbiol, 2023, 13:1131641
-
Front Cell Infect Microbiol, 2022, 12:864912
|
|
S7092 |
SANT-1
|
SANT-1 directly binds to Smoothened (Smo) receptor with Kd of 1.2 nM and inhibits Smo agonist effects with IC50 of 20 nM. |
-
Stem Cell Reports, 2024, 19(7):973-992
-
Front Immunol, 2023, 14:1258074
-
Nat Commun, 2022, 13(1):2407
|
|
S6384 |
SAG (Smoothened Agonist)
|
SAG (Smoothened Agonist) is a potent agonist of Smoothened (Smo). Smoothened Agonist induces firefly luciferase expression in Shh-LIGHT2 cells with an EC50 of 3 nM.
|
-
EBioMedicine, 2024, 101:105026
-
J Adv Res, 2024, S2090-1232(24)00106-1
-
iScience, 2024, 27(6):109967
|
|
S7138 |
BMS-833923
|
BMS-833923 (XL139) is an orally bioavailable Smoothened antagonist. Phase 2. |
-
Sci Rep, 2022, 12(1):7
-
Mol Cancer Res, 2021, molcanres.MCR-21-0257-A.2021
-
Carcinogenesis, 2020, 41(7):993-1004
|
|
S2157 |
Taladegib (LY2940680)
|
Taladegib (LY2940680) binds to the Smoothened (Smo) receptor and potently inhibits Hedgehog (Hh) signaling. Phase 1/2. |
-
Sci Rep, 2022, 12(1):7
-
Carcinogenesis, 2020, 41(7):993-1004
-
Front Pharmacol, 2019, 10:89
|
|
S8249 |
HPI-4 (Ciliobrevin A)
|
HPI-4 (Ciliobrevin A, Hedgehog Pathway Inhibitor 4) is a hedgehog (Hh) pathway antagonist. It blocks Sonic hedgehog (Shh)-induced Hh pathway activation (IC50 = 7 μM) downstream of Smo. |
-
Elife, 2023, 12e80040
-
Int J Mol Sci, 2022, 23(24)15573
-
Int J Mol Sci, 2022, 23(24)15573
|
|
S2777 |
PF-5274857
|
PF-5274857 is a potent and selective Smoothened (Smo) antagonist, inhibits Hedgehog (Hh) signaling with IC50 and Ki of 5.8 nM and 4.6 nM, respectively, and can penetrate the blood–brain barrier. |
-
Sci Rep, 2022, 12(1):7
-
Biol Reprod, 2021, ioab111
-
Carcinogenesis, 2020, 41(7):993-1004
|
|
S7160 |
Glasdegib
|
Glasdegib is a potent, and orally bioavailable Smoothened (Smo) inhibitor with IC50 of 5 nM. Phase 2.
|
-
Leukemia, 2023, 37(8):1649-1659
-
Front Cell Dev Biol, 2021, 9:662868
-
Genome Med, 2020, 18;12(1):17
|
|
S4747 |
Jervine
|
Jervine (11-Ketocyclopamine) is a Hedgehog signaling (IC50=500-700 nM) inhibitor that inhibits the sonic hedgehog (shh) pathway by interacting with smoothened. |
-
Sci Rep, 2022, 12(1):7
-
Neurochem Int, 2021, 146:105042
|
|
S9743 |
Ciliobrevin D
|
Ciliobrevin D (compound 5) is a cell-permeable, reversible and specific antagonist of AAA+ (ATPases associated with diverse cellular activities) ATPase motor cytoplasmic dynein. Ciliobrevin D perturbs primary cilia formation and blocks Hedgehog (Hh) signaling. |
-
ACS Chem Biol, 2024, 19(8):1733-1742
-
Mol Cell, 2022, S1097-2765(22)00327-6
-
J Cell Sci, 2022, 135(21)jcs259999
|
|
S8200 |
MK-4101
|
MK-4101, a potent inhibitor of the Hedgehog pathway, shows anti-tumor activity through the inhibition of proliferation and induction of extensive apoptosis in tumor cells. |
-
Sci Rep, 2022, 12(1):7
|
|
S6565 |
JK184
|
JK184 inhibits Gli in the Hedgehog (Hh) pathway with IC50 of 30 nM in mammalian cells. |
-
Cell Res, 2020, 10.1038/s41422-020-00426-0
|
|
E0787 |
ALLO-2
|
ALLO-2 is a potent antagonist of both wild-type mouse Smo and drug-resistant D473H mutant human Smo that inhibits Smo agonist inhibited Gli-Luc activity in TM3-Gli-Luc cells with IC50 of 6 nM. |
|
|
E0480 |
MRT-81
|
MRT-81 is a potent antagonist of human and rodent smoothened (Smo) receptors, with an IC50 value of 41 nM in the Shh-light2 cells, exerting potent hedgehog (Hh) signaling pathway inhibiting activity. |
|
|
E0782 |
MRT 10
|
MRT-10 inhibits ShhN signaling in Shh-light2 cells in a dose-dependent manner with IC50 of 0.64 μM, showing the capacity to abrogate the constitutive activity of Smo. |
|
|
S1082 |
Vismodegib (GDC-0449)
|
Vismodegib (GDC-0449) is a potent, novel and specific hedgehog inhibitor with IC50 of 3 nM and also inhibits P-gp with IC50 of 3.0 μM in a cell-free assay. |
- Nat Commun, 2024, 15(1):8134
- EBioMedicine, 2024, 101:105026
- EMBO Rep, 2024, 25(5):2188-2201
|
|
S8075 |
GANT61
|
GANT61 (NSC 136476) is an inhibitor for GLI1 as well as GLI2-induced transcription, inhibits hedgehog with IC50 of 5 μM in GLI1 expressing HEK293T cell, displays selectivity over other pathways, such as TNF and glucocorticoid receptor gene transactivation. GANT61 induces apoptosis and activates protective autophagy in LX-2 cells. |
- EBioMedicine, 2024, 101:105026
- Acta Pharm Sin B, 2023, 13(6):2601-2612
- Acta Pharm Sin B, 2023, 13(6):2601-2612
|
|
S2476 |
Itraconazole
|
Itraconazole is a relatively potent inhibitor of CYP3A4 with IC50 of 6.1 nM, used as a triazole antifungal agent. Itraconazole is a potent antagonist of the Hedgehog (Hh) signaling pathway. Itraconazole suppresses the growth of glioblastoma through induction of autophagy. |
- Front Cell Infect Microbiol, 2023, 13:1128000
- Front Cell Infect Microbiol, 2023, 13:1131641
- Front Cell Infect Microbiol, 2022, 12:864912
|
|
S2157 |
Taladegib (LY2940680)
|
Taladegib (LY2940680) binds to the Smoothened (Smo) receptor and potently inhibits Hedgehog (Hh) signaling. Phase 1/2. |
- Sci Rep, 2022, 12(1):7
- Carcinogenesis, 2020, 41(7):993-1004
- Front Pharmacol, 2019, 10:89
|
|
S8249 |
HPI-4 (Ciliobrevin A)
|
HPI-4 (Ciliobrevin A, Hedgehog Pathway Inhibitor 4) is a hedgehog (Hh) pathway antagonist. It blocks Sonic hedgehog (Shh)-induced Hh pathway activation (IC50 = 7 μM) downstream of Smo. |
- Elife, 2023, 12e80040
- Int J Mol Sci, 2022, 23(24)15573
- Int J Mol Sci, 2022, 23(24)15573
|
|
S7160 |
Glasdegib
|
Glasdegib is a potent, and orally bioavailable Smoothened (Smo) inhibitor with IC50 of 5 nM. Phase 2.
|
- Leukemia, 2023, 37(8):1649-1659
- Front Cell Dev Biol, 2021, 9:662868
- Genome Med, 2020, 18;12(1):17
|
|
S4747 |
Jervine
|
Jervine (11-Ketocyclopamine) is a Hedgehog signaling (IC50=500-700 nM) inhibitor that inhibits the sonic hedgehog (shh) pathway by interacting with smoothened. |
- Sci Rep, 2022, 12(1):7
- Neurochem Int, 2021, 146:105042
|
|
S9743 |
Ciliobrevin D
|
Ciliobrevin D (compound 5) is a cell-permeable, reversible and specific antagonist of AAA+ (ATPases associated with diverse cellular activities) ATPase motor cytoplasmic dynein. Ciliobrevin D perturbs primary cilia formation and blocks Hedgehog (Hh) signaling. |
- ACS Chem Biol, 2024, 19(8):1733-1742
- Mol Cell, 2022, S1097-2765(22)00327-6
- J Cell Sci, 2022, 135(21)jcs259999
|
|
S8200 |
MK-4101
|
MK-4101, a potent inhibitor of the Hedgehog pathway, shows anti-tumor activity through the inhibition of proliferation and induction of extensive apoptosis in tumor cells. |
- Sci Rep, 2022, 12(1):7
|
|
S6565 |
JK184
|
JK184 inhibits Gli in the Hedgehog (Hh) pathway with IC50 of 30 nM in mammalian cells. |
- Cell Res, 2020, 10.1038/s41422-020-00426-0
|
|
E0782 |
MRT 10
|
MRT-10 inhibits ShhN signaling in Shh-light2 cells in a dose-dependent manner with IC50 of 0.64 μM, showing the capacity to abrogate the constitutive activity of Smo. |
|
|
S1146 |
Cyclopamine
|
Cyclopamine (11-deoxojervine) is a specific Hedgehog (Hh) signaling pathway antagonist of Smoothened (Smo) with IC50 of 46 nM in TM3Hh12 cells. |
- Nat Commun, 2024, 15(1):987
- Cell Oncol (Dordr), 2024, 10.1007/s13402-024-00939-5
- Front Cell Dev Biol, 2024, 12:1356589
|
|
S2151 |
Sonidegib
|
Sonidegib is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human) in cell-free assays, respectively. Phase 3. |
- EBioMedicine, 2024, 101:105026
- Cell Death Dis, 2024, 15(1):56
- Cell Rep, 2024, 43(8):114532
|
|
S7092 |
SANT-1
|
SANT-1 directly binds to Smoothened (Smo) receptor with Kd of 1.2 nM and inhibits Smo agonist effects with IC50 of 20 nM. |
- Stem Cell Reports, 2024, 19(7):973-992
- Front Immunol, 2023, 14:1258074
- Nat Commun, 2022, 13(1):2407
|
|
S7138 |
BMS-833923
|
BMS-833923 (XL139) is an orally bioavailable Smoothened antagonist. Phase 2. |
- Sci Rep, 2022, 12(1):7
- Mol Cancer Res, 2021, molcanres.MCR-21-0257-A.2021
- Carcinogenesis, 2020, 41(7):993-1004
|
|
S2777 |
PF-5274857
|
PF-5274857 is a potent and selective Smoothened (Smo) antagonist, inhibits Hedgehog (Hh) signaling with IC50 and Ki of 5.8 nM and 4.6 nM, respectively, and can penetrate the blood–brain barrier. |
- Sci Rep, 2022, 12(1):7
- Biol Reprod, 2021, ioab111
- Carcinogenesis, 2020, 41(7):993-1004
|
|
E0787 |
ALLO-2
|
ALLO-2 is a potent antagonist of both wild-type mouse Smo and drug-resistant D473H mutant human Smo that inhibits Smo agonist inhibited Gli-Luc activity in TM3-Gli-Luc cells with IC50 of 6 nM. |
|
|
E0480 |
MRT-81
|
MRT-81 is a potent antagonist of human and rodent smoothened (Smo) receptors, with an IC50 value of 41 nM in the Shh-light2 cells, exerting potent hedgehog (Hh) signaling pathway inhibiting activity. |
|
|